Name Net increased
positions
Increased positions Reduced positions Return since
30 Sep ‘16
51
26 96 70 66.2%
52
26 75 49 38.3%
53
26 35 9 8.11%
VNDA icon
54
Vanda Pharmaceuticals
VNDA
$441M
26 57 31 55.1%
55
26 77 51 89.4%
56
26 88 62 74.1%
57
26 56 30 63.7%
58
26 62 36 55.6%
59
26 43 17 36.9%
60
26 70 44 94.9%
CLB icon
61
Core Laboratories
CLB
$905M
25 150 125 82.7%
62
25 62 37 47.3%
63
25 62 37 71.1%
64
25 70 45 84.1%
65
25 60 35 178%
66
25 52 27 3.64%
67
24 68 44 56.9%
68
24 43 19 42.4%
69
24 50 26 81.7%
70
24 57 33 20.6%
71
24 148 124 79%
72
24 65 41 77.4%
73
24 71 47 111%
74
24 51 27 171%
75
24 47 23 10.7%